Logo image
Comparing Metabolic Outcomes Associated with Aripiprazole and Olanzapine in Schizophrenia Spectrum Disorder: Insights from a Large Real-World Cohort Using TriNetX
Preprint   Open access

Comparing Metabolic Outcomes Associated with Aripiprazole and Olanzapine in Schizophrenia Spectrum Disorder: Insights from a Large Real-World Cohort Using TriNetX

Eduardo Espiridion
SSRN Electronic Journal
2026
url
https://dx.doi.org/10.2139/ssrn.6085826View
Preprint (Author's original)Open Access (License Unspecified) Open

Metrics

1 Record Views

Details

Logo image